Place of Death for Individuals With Chronic Lung Disease Trends and Associated Factors From 2003 to 2017 in the United States

被引:19
作者
Cross, Sarah H. [1 ]
Ely, E. Wesley [2 ,3 ,4 ]
Kavalieratos, Dio [5 ]
Tulsky, James A. [6 ,7 ]
Warraich, Haider J. [8 ,9 ]
机构
[1] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA
[2] Vanderbilt Univ, Med Ctr, Crit Illness Brain Dysfunct & Survivorship Ctr, Nashville, TN USA
[3] VA Tennessee Valley Geriatr Res Educ Clin Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, 221 Kirkland Hall, Nashville, TN 37235 USA
[5] Univ Pittsburgh, Dept Med, Div Gen Internal Med, Sect Palliat Care & Med Eth, Pittsburgh, PA USA
[6] Brigham & Womens Hosp, Dept Med, Div Palliat Med, 75 Francis St, Boston, MA 02115 USA
[7] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA
[8] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA
[9] Boston VA Healthcare Syst, Dept Med, Cardiol Sect, Boston, MA USA
基金
美国国家卫生研究院;
关键词
COPD; cystic fibrosis; home; interstitial lung disease; palliative care; OF-LIFE CARE; OBSTRUCTIVE PULMONARY-DISEASE; PALLIATIVE CARE; HEART-DISEASE; END; CANCER; COPD; MISDIAGNOSIS; DISPARITIES; MORTALITY;
D O I
10.1016/j.chest.2020.02.062
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Although chronic lung disease is a common cause of mortality, little is known about where individuals with chronic lung disease die. RESEARCH QUESTION: The aim of this study was to determine the trends and factors associated with place of death among individuals with chronic lung disease. STUDY DESIGN AND METHODS: This cross-sectional analysis of natural deaths was conducted by using the Centers for Disease Control and Prevention Wide-ranging OnLine Data for Epidemiologic Research from 2003 to 2017 for which COPD, interstitial lung disease (ILD), or cystic fibrosis (CF) was the underlying cause. Place of death was categorized as hospital, home, nursing facility, hospice facility, and other. RESULTS: From 2003 to 2017, more than 2.2. million deaths were primarily attributed to chronic lung disease (51.6% female, 92.4% white). Most were attributed to COPD (88.9%), followed by ILD (10.8.%), and CF (0.3%). Hospital and nursing facility deaths declined from 44.4% (n = 59,470) and 22.6% (n = 30,285) to 28.3% (n = 49,655) and 19.7% (n = 34,495), while home and hospice facility deaths increased from 23.3% (n = 31,296) and 0.1% (n = 192) to 34.7% (n = 60,851) and 9.0% (n = 15,861), respectively. Male sex, being married, and having some college education were associated with increased odds of home death, whereas non-white race and Hispanic ethnicity were associated with increased odds of hospital death. Compared with individuals with COPD, individuals with ILD and CF had increased odds of hospital death and reduced odds of home, nursing facility, or hospice facility death. INTERPRETATION: Home deaths are rising among decedents from chronic lung disease, increasing the need for quality end-of-life care in this setting. Further research should explore the end-of-life needs and preferences of these patients and their caregivers, with particular attention paid to patients with ILD and CF who continue to have high rates of hospital death.
引用
收藏
页码:670 / 680
页数:11
相关论文
共 51 条
[1]   End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study [J].
Ahmadi, Zainab ;
Wysham, Nicholas G. ;
Lundstrom, Staffan ;
Janson, Christer ;
Currow, David C. ;
Ekstrom, Magnus .
THORAX, 2016, 71 (06) :510-516
[2]  
[Anonymous], LEAD CAUS DEATH
[3]   Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer [J].
Au, DH ;
Udris, EM ;
Fihn, SD ;
McDonell, MB ;
Curtis, JR .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (03) :326-331
[4]   Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention [J].
Bajwah, Sabrina ;
Ross, Joy R. ;
Wells, Athol U. ;
Mohammed, Kabir ;
Oyebode, Christina ;
Birring, Surinder S. ;
Patel, Amit S. ;
Koffman, Jonathan ;
Higginson, Irene J. ;
Riley, Julia .
THORAX, 2015, 70 (09) :830-839
[5]   'I wish I knew more...' the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals [J].
Bajwah, Sabrina ;
Koffman, Jonathan ;
Higginson, Irene J. ;
Ross, Joy R. ;
Wells, Athol U. ;
Birring, Surinder S. ;
Riley, Julia .
BMJ SUPPORTIVE & PALLIATIVE CARE, 2013, 3 (01) :84-90
[6]   The palliative care needs for fibrotic interstitial lung disease: A qualitative study of patients, informal caregivers and health professionals [J].
Bajwah, Sabrina ;
Higginson, Irene J. ;
Ross, Joy R. ;
Wells, Athol U. ;
Birring, Surinder S. ;
Riley, Julia ;
Koffman, Jonathan .
PALLIATIVE MEDICINE, 2013, 27 (09) :869-876
[7]   Referral to palliative care in COPD and other chronic diseases: A population-based study [J].
Beernaert, Kim ;
Cohen, Joachim ;
Deliens, Luc ;
Devroey, Dirk ;
Vanthomme, Katrien ;
Pardon, Koen ;
Van den Block, Lieve .
RESPIRATORY MEDICINE, 2013, 107 (11) :1731-1739
[8]   Factors Associated with Congruence Between Preferred and Actual Place of Death [J].
Bell, Christina L. ;
Somogyi-Zalud, Emese ;
Masaki, Kamal H. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (03) :591-604
[9]   Palliative care of chronic progressive lung disease [J].
Bourke, S. J. ;
Peel, E. T. .
CLINICAL MEDICINE, 2014, 14 (01) :79-82
[10]   Inadequate Palliative Care in Chronic Lung Disease An Issue of Health Care Inequality [J].
Brown, Crystal E. ;
Jecker, Nancy S. ;
Curtis, J. Randall .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (03) :311-316